DES y resistencia plaquetaria: implicancia clínica.

viernes1155hornez
Erick Hórnez
2011-05-13

More articles by this author

Intervencionismo en el siglo XXI, nuestras fronteras.

Daniel Berrocal2011-05-13

DES en el Síndrome coronario agudo.

Carlos Benítez2011-05-13

Puentes Venosos

Ariel Durán2011-05-13

IAM con ST y enfermedad de multiples vasos: nuevos paradigmas.

Daniel Berrocal2011-05-13

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....